A multicenter observational study in Japan published in the Frontiers in Clinical Diabetes and Healthcare found that individuals with type 2 diabetes taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) showed reduced external eating scores after 12 months of therapy Their blood sugar levels, body weight, and body fat percentage also decreased significantly Emotional and restrained eating showed only transient changes
Mild GI effects (nausea, fullness) as your body adapts
More recently, it has gained recognitionand FDA approvalfor its remarkable effectiveness in supporting safe, sustainable weight loss
This leads to a scenario where new therapeutic strategies for diabetes must inevitably consider not only glycemic and weight control but also the reduction of both vascular and non-vascular complications
Berberine is a naturally occurring alkaloid compound extracted from various plants, including Berberis species (barberry), goldenseal, and Chinese goldthread
Branched-Chain Amino Acid Metabolism Is Regulated by ERR in Primary Human Myotubes and Is Further Impaired by Glucose Loading in Type 2 Diabetes
